Algorithms developed by University of Florida Health (UF Health) researchers employ artificial intelligence (AI) to forecast outcomes from treatments for hepatitis C.
Four algorithms were trained on almost 5,000 patient samples from a national hepatitis C registry, and can generate treatment-failure predictions that outperform multivariable logistic regression methods.
Another 1,631 patient samples separately validated the algorithms' efficacy.
Some of the research was executed with HiPerGator, Florida's most powerful supercomputer.
The most accurate algorithm was the gradient boosting machine, which distinguished itself by being able to identify patients at highest risk of treatment failure and segment them into different risk groups. UF Health's Haesuk Park described the algorithm as "the first AI model developed to predict direct-acting antiviral treatment failure," calling it "a good foundation for future research."
From UF Health
View Full Article
Abstracts Copyright © 2022 SmithBucklin, Washington, DC, USA
No entries found